Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Yarmolinsky

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Ebiomedicine|September 15, 2024
Circulating inflammatory and immune response proteins and endometrial cancer risk: a nested case-control study and Mendelian randomization analysesSabrina E Wang, Vivian Viallon, Matthew Lee, et al.
Journal of the National Cancer Institute|June 13, 2025
Proteogenomic and observational evidence implicate ANGPTL4 as a potential therapeutic target for colorectal cancer preventionJames Yarmolinsky, Matthew A Lee, Evelyn Lau, et al.
Journal of the National Cancer Institute|April 22, 2026
Premenopausal and postmenopausal obesity and endometrial cancer risk: circulating biomarkers of inflammation, insulin resistance, and sex hormones as mediatorsSabrina E Wang, Vivian Viallon, Carine Biessy, et al.
Ebiomedicine|February 4, 2026
Autoencoders reveal polyunsaturated fatty acids (PUFA)-Related metabolic signature linked to cancer riskMarie Breeur, Joshua Atkins, Laia Peruchet-Noray, et al.
Cell Reports. Medicine|August 21, 2024
The effect of SGLT2 inhibition on prostate cancer: Mendelian randomization and observational analysis using electronic healthcare and cohort dataJie Zheng, Jieli Lu, Jiying Qi, et al.
Nature Genetics|September 8, 2020
Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseasesJie Zheng, Valeriia Haberland, Denis Baird, et al.
BMC Medicine|January 11, 2022
Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysisEmmanouil Bouras, Ville Karhunen, Dipender Gill, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2023
Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysisJames Yarmolinsky, Jamie W Robinson, Daniela Mariosa, et al.
Cancer Causes & Control : CCC|March 11, 2022
Applying Mendelian randomization to appraise causality in relationships between nutrition and cancerKaitlin H Wade, James Yarmolinsky, Edward Giovannucci, et al.
Ebiomedicine|February 1, 2024
Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysisJames Yarmolinsky, Jamie W Robinson, Daniela Mariosa, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Ebiomedicine|September 15, 2024
Circulating inflammatory and immune response proteins and endometrial cancer risk: a nested case-control study and Mendelian randomization analysesSabrina E Wang, Vivian Viallon, Matthew Lee, et al.
Journal of the National Cancer Institute|June 13, 2025
Proteogenomic and observational evidence implicate ANGPTL4 as a potential therapeutic target for colorectal cancer preventionJames Yarmolinsky, Matthew A Lee, Evelyn Lau, et al.
Journal of the National Cancer Institute|April 22, 2026
Premenopausal and postmenopausal obesity and endometrial cancer risk: circulating biomarkers of inflammation, insulin resistance, and sex hormones as mediatorsSabrina E Wang, Vivian Viallon, Carine Biessy, et al.
Ebiomedicine|February 4, 2026
Autoencoders reveal polyunsaturated fatty acids (PUFA)-Related metabolic signature linked to cancer riskMarie Breeur, Joshua Atkins, Laia Peruchet-Noray, et al.
Cell Reports. Medicine|August 21, 2024
The effect of SGLT2 inhibition on prostate cancer: Mendelian randomization and observational analysis using electronic healthcare and cohort dataJie Zheng, Jieli Lu, Jiying Qi, et al.
Nature Genetics|September 8, 2020
Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseasesJie Zheng, Valeriia Haberland, Denis Baird, et al.
BMC Medicine|January 11, 2022
Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysisEmmanouil Bouras, Ville Karhunen, Dipender Gill, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2023
Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysisJames Yarmolinsky, Jamie W Robinson, Daniela Mariosa, et al.
Cancer Causes & Control : CCC|March 11, 2022
Applying Mendelian randomization to appraise causality in relationships between nutrition and cancerKaitlin H Wade, James Yarmolinsky, Edward Giovannucci, et al.
Ebiomedicine|February 1, 2024
Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysisJames Yarmolinsky, Jamie W Robinson, Daniela Mariosa, et al.
Pageof 7